Insta
Acharya Prafulla Chandra Ray.
Central Public Sector Undertaking Bengal Chemicals and Pharmaceuticals Limited (BCPL) on Friday (10 April) got clearance from drug control authorities to manufacture Hydroxychloroquine, which is being considered effective in treating Covid-19 patients.
The company got the licence days after the union government took the initiative for large-scale manufacture of the drug in view of the raging pandemic.
According to the company chairman P.M. Chandraiya, BCPL has the capability to churn out 10 lakh hydroxychloroquine tablets daily.
Founded in 1901, BCPL is the country's first pharmaceutical company, and once manufactured Hydroychloroquine. However, it stopped manufacturing the product decades back.
Chandraiya said the cost of raw materials for making the drug has gone up 20 times in the past few weeks.
"We have requested the union government to put a cap on the raw material prices," he said.
This news has been published via Syndicate feed. Only the headline has been changed.
Support Swarajya's 50 Ground Reports Project & Sponsor A Story
Every general election Swarajya does a 50 ground reports project.
Aimed only at serious readers and those who appreciate the nuances of political undercurrents, the project provides a sense of India's electoral landscape. As you know, these reports are produced after considerable investment of travel, time and effort on the ground.
This time too we've kicked off the project in style and have covered over 30 constituencies already. If you're someone who appreciates such work and have enjoyed our coverage please consider sponsoring a ground report for just Rs 2999 to Rs 19,999 - it goes a long way in helping us produce more quality reportage.
You can also back this project by becoming a subscriber for as little as Rs 999 - so do click on this links and choose a plan that suits you and back us.
Click below to contribute.
Latest